Moderna (NASDAQ: MRNA)
Moderna Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Moderna Company Info
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA).
News & Analysis
Moderna Stock: Bull vs. Bear
This stock delivered spectacular gains in the past.
1 (Bad) Reason to Sell Moderna Stock Right Now, and 2 Good Reasons to Buy It
Sometimes bad news is a bad reason to sell.
Where Will Moderna Stock Be in 5 Years?
Can Moderna be a good stock to buy if it can no longer count on billions in revenue from its COVID vaccine?
3 Reasons to Buy Moderna Stock
The company can still deliver excellent returns.
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
The futures for these two beaten-down stocks could be brighter than their recent pasts.
Moderna Stock Has 33% Upside, According to 1 Wall Street Analyst
A lot is riding on whether there will be demand for its new vaccines.
Why Moderna Stock Is Jumping Today
The biotech company surprised investors with a Q4 profit.
If You Invested $10,000 in Moderna in 2019, This Is How Much You Would Have Today
Moderna generated billions of dollars in earnings from its coronavirus vaccine.
Valuation
Podcast Episodes
Microsoft's Gaming Ambitions and COVID-19 Stocks
Microsoft CEO Satya Nadella talked about his company's doubling down on gaming, which should give gamers and investors pause.
What Gives Moderna's Coronavirus Vaccine an Edge?
Moderna has got some promising news on the coronavirus vaccine front.
Why Moderna Stock Is Up
Moderna shares got a boost as the company continued its COVID-19 vaccine trials.
Why Moderna Stock Just Went Up
Encouraging news coming out of the biotech regarding its coronavirus vaccine candidate caused its stock to pop.
Earnings Transcripts
Moderna (MRNA) Q4 2023 Earnings Call Transcript
MRNA earnings call for the period ending December 31, 2023.
Moderna (MRNA) Q3 2023 Earnings Call Transcript
MRNA earnings call for the period ending September 30, 2023.
Moderna (MRNA) Q2 2023 Earnings Call Transcript
MRNA earnings call for the period ending June 30, 2023.
Moderna (MRNA) Q1 2023 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.